Redox regulation of cardiomyocyte survival and death

Antioxidants and Redox Signaling

Volumn 3, Issue 1, 2001, Pages 23-37

  Das, D K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL DEATH; CELL REGENERATION; CELL SURVIVAL; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035078954     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601750100461     Document Type: Review

References (71)

1. Requirement for integration of signals from two distinct phosphorylation pathways for activation of Map kinase
2. An essential role for NFκB in preventing TNE-alpha-induced cell death
3. Facilitation of signal onset and termination by adenylyl cyclase
4. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
5. Apoptosis in the heart; when and why
6. Thymocyte apoptosis induced by p53-dependent and independent pathways
7. How MAP kinases are regulated
8. Phospholipase D plays a major role in ischemic preconditioning in rabbit heart
9. Regulation of gene expression by reactive oxygen
10. Ischemic preconditioning: Role of multiple kinases in signal amplification and modulation
11. Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischemia
12. Detection of hydroxyl radicals in the mitochondria of ischemic-reperfused myocardium by trapping with salicylate
13. Evaluation of antioxidant effectiveness in ischemia reperfusion tissue injury methods
14. Apoptosis in ischemia reperfusion injury
15. Protection against free radical injury in the heart and cardiac performance
16. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia/reperfusion, hyperthermia and oxidative stress
17. Reactive oxygen species function as second messenger during ischemic preconditioning of heart
18. Intracellular proteolytic systems may function as secondary antioxidant defenses: A hypothesis
19. Bradykinin and angiotensin II: Activation of protein kinase C in arterial muscle
20. Exploration of the possible roles of phospholipase D and protein kinase C in the mechanism of ischemic preconditioning in the myocardium
21. Pre-treatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts
22. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy
23. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart
24. Do reactive oxygen species underlie the mechanism of apoptosis in the tadpole tail?
25. 1-adrenergic and phorbol ester stimulation
26. Redox regulation of signal transduction in mammalian cells
27. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo
28. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation
29. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
30. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: Modulation of proto-oncogene expression
31. Oxygen radicals, neutrophil-derived oxidants, amyocardial reperfusion injury
32. The stress-activated protein kinase subfamily of c-Jun kinases
33. Death by design. Programmed cell death in cardiovascular biology and disease
34. Apoptosis, heart failure, ischemic heart disease
35. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2
36. Differential regulation of Bcl-2, AP-1 and NFκB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation
37. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis
38. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors
39. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium
40. Oxidative stress adaptation improves postischemic ventricular recovery
41. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin
42. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts
43. Interleukin-1α preconditioning reduces myocardial ischemic reperfusion injury
44. Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutatione peroxidase
45. Oxidative stress developed during the reperfusion of ischemic my induces apoptosis
46. Ischemic preconditioning triggers tyrosine kinase signaling: Potential role for MAPKAP kinase 2
47. Role of primary response genes in generating cellular responses to growth factors
48. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart
49. Preconditioning of isolated rat heart is mediated by protein kinase C
50. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
51. Phospholipase D signaling in ischemic heart
52. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats
53. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
54. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
55. Inhibition of neutrophil apoptosis by antioxidants in culture medium
56. Apoptosis in the failing human heart
57. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
58. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors
59. SAPKs regulation of ischemic preconditioning
60. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFκB transcription factor and HIV-1
61. The MAPK signaling cascade
62. Role of cytokines in myocardial ischemia and reperfusion
63. Inhibition of NFκB DNA binding activity by α-tocopheryl succinate
64. α-Lipoic acid is a potent inhibitor of NFκB activation in human T cells
65. Expression of heat shock protein after ischemic preconditioning in rabbit hearts
66. Caspases: Enemies within
67. Effects of SOD, catalase and a novel anti-arrhythmic drug, EGB 671, on reperfusion-induced arrhythmias in isolated rat hearts
68. The role of protein kinase C in ischemic/reperfused preconditioning isolated rat hearts
69. Molecular regulation of apoptosis: Genetic controls on cell death
70. Role of protein kinase system in the signal transduction of stretch-mediated protooncogene expression and hypertrophy of cardiac myocytes
71. High expression and activation of MAP kinase-activated protein kinase 2 in cardiac muscle cells